International Clinical Trial: Investigating the safety and efficacy of the early use of plerixafor in healthy stem cell donors

Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ISRCTN73055142) titled 'Investigating the safety and efficacy of the early use of plerixafor in healthy stem cell donors' on Oct. 21.

Study Type: Interventional

Study Design: Allocation: Non-randomized controlled trial Masking: Open (masking not used) Control: Uncontrolled Assignment: Single Purpose: Treatment, Safety

Primary Sponsor: Royal Marsden NHS Foundation Trust

Condition: Healthy volunteer donors for stem cell transplantation Other

Intervention: This is a phase II, single-arm, prospective proof-of-concept study in healthy adult allogeneic stem cell donors. Donors are screened using the Anthony Nolan mobilisation prediction ...